Literature DB >> 19060546

Hypogammaglobulinemia and infection risk in solid organ transplant recipients.

Steven Mawhorter1, Mohamad H Yamani.   

Abstract

PURPOSE OF REVIEW: Hypogammaglobulinemia may develop as a result of a number of immune deficiency syndromes that can be devastating. This review article explores the risk of infection associated with hypogammaglobulinemia in solid organ transplantation and discusses therapeutic strategies to alleviate such a risk. RECENT
FINDINGS: Hypogammaglobulinemia is associated with increased risk of opportunistic infections, particularly during the 6-month posttransplant period when viral infections are most prevalent. The preemptive use of immunoglobulin replacement results in a significant reduction of opportunistic infections in patients with moderate and severe hypogammaglobulinemia.
SUMMARY: Monitoring immunoglobulin G levels may aid in clinical management of solid organ transplant recipients. The preemptive use of immunoglobulin replacement may serve as a new strategy for managing solid organ transplant recipients with hypogammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060546     DOI: 10.1097/MOT.0b013e3283186bbc

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  14 in total

1.  Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.

Authors:  E A Engels; J Preiksaitis; A Zingone; O Landgren
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

2.  Solid organ transplantation: hypogammaglobulinaemia and infectious complications after solid organ transplantation.

Authors:  D F Florescu
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

3.  Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients.

Authors:  Cécile Courivaud; Karine Bardonnet; Thomas Crepin; Catherine Bresson-Vautrin; Jean-Michel Rebibou; Didier Ducloux
Journal:  J Nephrol       Date:  2015-03-11       Impact factor: 3.902

Review 4.  Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer.

Authors:  Eric A Engels
Journal:  Am J Transplant       Date:  2019-07-08       Impact factor: 8.086

5.  Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients.

Authors:  Eric A Engels; Barbara Savoldo; Ruth M Pfeiffer; Rene Costello; Adriana Zingone; Helen E Heslop; Ola Landgren
Journal:  Transplantation       Date:  2013-02-15       Impact factor: 4.939

6.  Incidence, timing, and significance of early hypogammaglobulinemia after intestinal transplantation.

Authors:  Douglas G Farmer; Omar M Kattan; Laura J Wozniak; Elizabeth Marcus; Susan Ponthieux; Villy Hwang; Ronald W Busuttil; Suzanne V McDiarmid; Robert S Venick
Journal:  Transplantation       Date:  2013-05-15       Impact factor: 4.939

7.  Acquired hypogammaglobulinemia in HIV-positive subjects after liver transplantation.

Authors:  K S Gregg; B Barin; D Pitrak; C Ramaprasad; K Pursell
Journal:  Transpl Infect Dis       Date:  2013-09-18       Impact factor: 2.228

8.  Acquired hypogammaglobulinemia and pathogen-specific antibody depletion after solid organ transplantation in human immunodeficiency virus infection: A brief report.

Authors:  Margaret Newman; Kevin Gregg; Randee Estes; Kenneth Pursell; David Pitrak
Journal:  Transpl Infect Dis       Date:  2019-10-14       Impact factor: 2.228

9.  Bilateral lung transplantation in a patient with humoral immune deficiency: a case report with review of the literature.

Authors:  Jocelyn R Farmer; Caroline L Sokol; Francisco A Bonilla; Mandakolathur R Murali; Richard L Kradin; Todd L Astor; Jolan E Walter
Journal:  Case Reports Immunol       Date:  2014-10-15

Review 10.  Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation.

Authors:  Mario Fernández-Ruiz; Deepali Kumar; Atul Humar
Journal:  Clin Transl Immunology       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.